These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8444514)

  • 1. Unchanged protein binding of penbutolol in renal insufficiency: a possible role of carbamylation.
    Aguirre C; Calvo R; Rodriguez-Sasiain JM
    Int J Clin Pharmacol Ther Toxicol; 1993 Jan; 31(1):31-4. PubMed ID: 8444514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein binding of itraconazole and fluconazole in patients with chronic renal failure.
    Arredondo G; Martinez-Jorda R; Calvo R; Aguirre C; Suarez E
    Int J Clin Pharmacol Ther; 1994 Jul; 32(7):361-4. PubMed ID: 7952798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum protein binding of penbutolol in patients with hepatic cirrhosis.
    Aguirre C; Calvo R; Rodríguez Sasiaín JM
    Int J Clin Pharmacol Ther Toxicol; 1988 Nov; 26(11):566-9. PubMed ID: 3243661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of serum protein binding of felodipine.
    Valle M; Esteban M; Rodríguez-Sasiaín JM; Calvo R; Aguirre C
    Res Commun Mol Pathol Pharmacol; 1996 Oct; 94(1):73-88. PubMed ID: 8948016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacodynamics of penbutolol in healthy and cancer subjects: role of altered protein binding.
    Aguirre C; Trocóniz IF; Valdivieso A; Jiménez RM; González JP; Calvo R; Rodríguez-Sasiaín JM
    Res Commun Mol Pathol Pharmacol; 1996 Apr; 92(1):53-72. PubMed ID: 8733828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma protein binding of penbutolol in pregnancy.
    Aquirre C; Rodriguez-Sasiain JM; Navajas P; Calvo R
    Eur J Drug Metab Pharmacokinet; 1988; 13(1):23-6. PubMed ID: 3396610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum binding of ketoconazole in health and disease.
    Martínez-Jordá R; Rodriguez-Sasiain JM; Suárez E; Calvo R
    Int J Clin Pharmacol Res; 1990; 10(5):271-6. PubMed ID: 2079384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein binding studies of furosemide and penbutolol.
    Gottschalk R; Sistovaris N
    Arzneimittelforschung; 1985; 35(6):899-902. PubMed ID: 4026914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of alfentanil to human alpha 1-acid glycoprotein, albumin and serum.
    Belpaire FM; Bogaert MG
    Int J Clin Pharmacol Ther Toxicol; 1991 Mar; 29(3):96-102. PubMed ID: 2071261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decrease in penbutolol central response as a cause of changes in its serum protein binding.
    Martínez Jordá R; Aguirre C; Calvo R; Rodríguez-Sasiaín JM; Erill S
    J Pharm Pharmacol; 1990 Mar; 42(3):164-6. PubMed ID: 1974610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma protein binding of zolpidem in liver and renal insufficiency.
    Pacifici GM; Viani A; Rizzo G; Carrai M; Ganansia J; Bianchetti G; Morselli PL
    Int J Clin Pharmacol Ther Toxicol; 1988 Sep; 26(9):439-43. PubMed ID: 3198298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma protein carbamylation and decreased acidic drug protein binding in uremia.
    Erill S; Calvo R; Carlos R
    Clin Pharmacol Ther; 1980 May; 27(5):612-8. PubMed ID: 7371359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study of the binding characteristics of chlorophenoxyisobutyric acid to serum proteins in chronically uremic patients : influence of dialysis and heparine (author's transl)].
    Lacour B; Di Giulio S; Nicolaï A; Drüeke T; Debray M; Boulu RG
    Nephrologie; 1982; 3(1):19-22. PubMed ID: 7088259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decrease in penbutolol protein binding as a consequence of treatment with some alkylating agents.
    Aguirre C; Rodríguez-Sasiain JM; Calvo R
    Cancer Chemother Pharmacol; 1994; 34(1):86-8. PubMed ID: 8174208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors affecting serum protein binding of cocaine in humans.
    Parker RB; Williams CL; Laizure SC; Lima JJ
    J Pharmacol Exp Ther; 1995 Nov; 275(2):605-10. PubMed ID: 7473145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interindividual variability in the concentrations of albumin and alpha-1-acid glycoprotein in patients with renal or liver disease, newborns and healthy subjects: implications for binding of drugs.
    Viani A; Rizzo G; Carrai M; Pacifici GM
    Int J Clin Pharmacol Ther Toxicol; 1992 Apr; 30(4):128-33. PubMed ID: 1572757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urea-derived cyanate forms epsilon-amino-carbamoyl-lysine (homocitrulline) in leukocyte proteins in patients with end-stage renal disease on peritoneal dialysis.
    Kraus LM; Elberger AJ; Handorf CR; Pabst MJ; Kraus AP
    J Lab Clin Med; 1994 Jun; 123(6):882-91. PubMed ID: 8201267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbamylation of proteins and sulfacetamide free fraction in serum in experimentally-induced high blood urea states.
    Erill S; du Souich P; Courteau H
    Res Commun Chem Pathol Pharmacol; 1985 Oct; 50(1):45-56. PubMed ID: 4081313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein binding of itraconazole and fluconazole in patients with cancer.
    Arredondo G; Calvo R; Marcos F; Martínez-Jordá R; Suarez E
    Int J Clin Pharmacol Ther; 1995 Aug; 33(8):449-52. PubMed ID: 8556224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of nelfinavir binding to plasma proteins and the lack of drug displacement interactions.
    Motoya T; Thevanayagam LN; Blaschke TF; Au S; Stone JA; Jayewardene AL; Chi J; Aweeka FT
    HIV Med; 2006 Mar; 7(2):122-8. PubMed ID: 16420257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.